This innovative drug delivery system was tested in vitro, and the results confirmed its efficacy against cancer cell lines (caspase 3 and PARP dose-dependent cleavage) and minimal level of invasiveness due to the localized distribution of the drug [40]. This evidence concerns the gene CASP3 and cancer.